Cincinnati Insurance’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-183,500
Closed -$13.7M 82
2020
Q1
$13.7M Sell
183,500
-160,000
-47% -$11.1M 0.43% 48
2019
Q4
$22.3M Hold
343,500
0.55% 45
2019
Q3
$21.8M Hold
343,500
0.57% 45
2019
Q2
$23.2M Hold
343,500
0.62% 43
2019
Q1
$22.3M Hold
343,500
0.63% 44
2018
Q4
$21.5M Hold
343,500
0.67% 44
2018
Q3
$26.5M Buy
343,500
+267,500
+352% +$20.2M 0.74% 42
2018
Q2
$5.38M Hold
76,000
0.16% 54
2018
Q1
$5.73M Hold
76,000
0.17% 52
2017
Q4
$5.45M Hold
76,000
0.16% 55
2017
Q3
$6.16M Hold
76,000
0.18% 56
2017
Q2
$5.38M Hold
76,000
0.17% 55
2017
Q1
$5.16M Buy
+76,000
New +$5.34M 0.16% 54
2016
Q4
Sell
-805,200
Closed -$63.7M 70
2016
Q3
$63.7M Buy
805,200
+55,000
+7% +$4.47M 2.07% 20
2016
Q2
$62.6M Buy
750,200
+399,400
+114% +$35.4M 2.05% 21
2016
Q1
$32.2M Buy
350,800
+87,000
+33% +$7.85M 1.13% 36
2015
Q4
$26.7M Hold
263,800
0.97% 37
2015
Q3
$25.9M Buy
+263,800
New +$29.3M 0.99% 38

Other funds holding GILD

Cincinnati Insurance's GILD Position: Q2 2020 in Review

Cincinnati Insurance sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 183,500 shares — an estimated $13.7M sold.

Cincinnati Insurance first reported a position in GILD in Q3 2015 and held it in 18 quarters. The position peaked at $63.7M in Q3 2016. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Cincinnati Insurance reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Cincinnati Insurance sold 183,500 Gilead Sciences shares in Q2 2020, an estimated $13.7M.
  • Cincinnati Insurance first reported a position in Gilead Sciences in Q3 2015 and held it in 18 quarters.
  • Cincinnati Insurance's Gilead Sciences position peaked at $63.7M in Q3 2016.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Cincinnati Insurance's 13F filing for Q2 2020, filed 6 Aug 2020.